Skip to main content

Advertisement

SpringerLink
Log in

Journal Club

  • JOURNAL CLUB
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogenous disease. Lancet 2008;372:1107–1119.

    Article  PubMed  Google Scholar 

  2. Baugault V, Turmel J, St-Lauren J, et al. Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes. Eur Respir J 2009;33:740–746.

    Article  CAS  Google Scholar 

  3. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998;32:125–129.

    Article  CAS  PubMed  Google Scholar 

  4. Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007;7:547–555.

    Article  PubMed  Google Scholar 

  5. Katelaris CH, Carrozzi FM, Burke TV, et al. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol 2000;106:260–266.

    Article  CAS  PubMed  Google Scholar 

  6. Sue-Chu M, Karjalainen EM, Laitinen A, et al. Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers. Respiration 2000;67:417–425.

    Article  CAS  PubMed  Google Scholar 

  7. Tan RA, Spector SL. Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol 2002;89:226–236.

    Article  PubMed  Google Scholar 

  8. Weiler JM, Ryan EJ, United States Olympic Committee. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol 2000;106:267–271.

    Article  CAS  PubMed  Google Scholar 

  9. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804–813.

    Article  CAS  PubMed  Google Scholar 

  10. Yoshikawa T, Shoji S, Fujii T, et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998;12:879–884.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Anderson HR, Aytes JG, Sturdy PM, et al. Bronchodilator treatment and deaths from asthma: case-control study. BMJ 2005;330:117–119.

    Article  PubMed  Google Scholar 

  2. Gillissen A, Berdel D, Buhl R, et al. β2-Sympathomimetika: Gefahren in der Asthmatherapie? Lehren aus der SMART-Studie. Eine Stellungnahme der Deutschen Atemwegsliga. Dtsch Med Wochenschr 2007;132:33–39.

    Article  CAS  PubMed  Google Scholar 

  3. Martinez FD. Safety of long-acting beta-agonists — an urgent need to clear the air. N Engl J Med 2005; 353:2637–2639.

    Article  CAS  PubMed  Google Scholar 

  4. Nelson HS, Weiss ST, Bleeker ER, et al. The Salmeterol Multicenter Asthma Research Trial. A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15–26.

    Article  CAS  PubMed  Google Scholar 

  5. O’Byrne PM, Ädelroth E. β2 déjà vu. Chest 2006;129:3–5.

    Article  PubMed  Google Scholar 

  6. Sears MR, Ottosson A, Radner F, et al. Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 2009;33:21–32.

    Article  CAS  PubMed  Google Scholar 

  7. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391–1396.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Bateman ED, GINA Executive and Science Committee. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Bethesda: U.S. Department of Health and Human Services, 2008.

    Google Scholar 

  2. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005–1012.

    Article  CAS  PubMed  Google Scholar 

  3. Fabbri LM, Luppi F, Beghe B, et al. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204–212.

    Article  CAS  PubMed  Google Scholar 

  4. Gillissen A, Buhl R, Kardos P, et al. Studienendpunkte bei der chronisch-obstruktiven Lungenerkrankung (COPD): minimal clinically important difference. Pneumologie 2008;62:149–157.

    Article  CAS  PubMed  Google Scholar 

  5. Gillissen A, Glaab T, Buhl R. Klinische Bedeutung der forcierten Einsekundenkapazität (FEV1) bei chronisch-obstruktiver Lungenerkrankung (COPD). Med Klin 2009;104:119–124.

    Article  Google Scholar 

  6. Gillissen A, Wirtz H, Hoheisel GB. Paradigmenwechsel in der Therapieempfehlung des Asthma bronchiale. Med Klin 2007;102:399–403.

    Article  Google Scholar 

  7. GOLD Executive Committee. Global initiative for chronic obstructive lung disease. 2007 ( http://www.goldcopd.com ).

  8. Gross NJ. Outcome measurements in COPD: are we schizophrenic? Chest 2003;123:1325–1327.

    Article  PubMed  Google Scholar 

  9. Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 2003;138:969–973.

    CAS  PubMed  Google Scholar 

  10. Imfeld S, Bloch KE, Weder W, et al. The BODE index after lung volume reduction surgery correlates with survival. Chest 2006;129:873–878.

    Article  PubMed  Google Scholar 

  11. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008;63:761–767.

    Article  CAS  PubMed  Google Scholar 

  12. Vandevoorde J, Varbanck S, Schuermanns D, et al. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005;127:1560–1564.

    Article  PubMed  Google Scholar 

  13. Verhage TL, Heijdra YF, Molema J, et al. Adequate patient characterization in COPD: reasons to go beyond GOLD classification. Open Respir Med J 2009;3:1–9.

    Article  PubMed  Google Scholar 

  14. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease ? Am J Crit Care Med 2002;166:329–332.

    Article  Google Scholar 

Literatur

  1. Lindor KD, Kowdley KV, Luketic VAC, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808–814.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Garcia-Pagan JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut 2009;58:1144–1150.

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. O’Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 2009;374:989–997.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. McAlister FA, Wiebe N, Ezekowitz JA, et al. Metaanalysis: β-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 2009;150:784–794.

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Club. Med Klin 104, 883–895 (2009). https://doi.org/10.1007/s00063-009-1186-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1186-4

Search

Navigation